Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia

✍ Scribed by Visani, G; Milligan, D; Leoni, F; Chang, J; Kelsey, S; Marcus, R; Powles, R; Schey, S; Covelli, A; Isidori, A

• Book ID: 110054886
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 130 KB
• Volume: 15
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2402117